Veracyte Inc banner

Wall St Price Targets

VCYT Price Forecast
Based on 13 analysts

+60% Upside
from $25.57 today

Veracyte Inc (VCYT)’s 12-month stock price forecast through November 2027 has a consensus target of $40.8, implying 60% upside. The forecast is based on price targets from 13 Wall Street analysts.

VCYT Analyst Rating
Based on 12 analysts

avg. 4.33 of 5
Strong buy
7 58%
Buy
2 17%
Hold
3 25%
Sell
0 0%
Strong sell
0 0%

Analysts rate VCYT Buy, with 9 of 12 recommending Buy or Strong buy.

Veracyte Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is VCYT's stock price target?
Price Target
40.8 USD

According to Wall Street analysts, the average 1-year price target for VCYT is 40.8 USD with a low forecast of 30.3 USD and a high forecast of 66.15 USD.

What is the Revenue forecast for Veracyte Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 6 years is 11%.

What is the Gross Profit forecast for Veracyte Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 6 years is 12%.

What is the Operating Income forecast for Veracyte Inc?
Projected CAGR
18%

The compound annual growth rate for Operating Income over the next 6 years is 18%.

What is the Pre-Tax Income forecast for Veracyte Inc?
Projected CAGR
38%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 38%.

What is the Net Income forecast for Veracyte Inc?
Projected CAGR
23%

The compound annual growth rate for Net Income over the next 6 years is 23%.

Back to Top